Bill

Bill > HB2378


VA HB2378

VA HB2378
Therapeutically equivalent drug products; provisions for return of outdated drugs.


summary

Introduced
01/08/2025
In Committee
02/13/2025
Crossed Over
02/03/2025
Passed
03/07/2025
Dead
Signed/Enacted/Adopted
03/21/2025

Introduced Session

2025 Regular Session

Bill Summary

Therapeutically equivalent drug products; provisions for return of outdated drugs. Requires drug manufacturers to implement provisions for the return of drugs past their expiration date by pharmacies in order for their products to be eligible for dispensing as a therapeutically equivalent drug.

AI Summary

This bill amends an existing Virginia law regarding the dispensing of therapeutically equivalent drug products by pharmacists. Specifically, the bill adds a new provision (Section E) that requires drug manufacturers to establish robust return policies for outdated drugs in order for their therapeutically equivalent drug products to be eligible for dispensing. Under this new requirement, manufacturers must create return provisions that allow pharmacies to return drugs in both full and partial containers up to six months after the label's expiration date, with the option of receiving full credit or a replacement product. This provision aims to ensure that pharmacies can safely and economically manage their drug inventory by providing a clear mechanism for returning expired medications. The bill maintains existing rules that allow pharmacists to substitute generic drugs for brand-name prescriptions unless the prescriber specifically prohibits substitution or the patient requests the brand-name drug, while also ensuring that substituted drugs are priced lower than the original prescribed medication.

Committee Categories

Education, Health and Social Services

Sponsors (1)

Last Action

Acts of Assembly Chapter text (CHAP0270) (on 03/21/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...